Sort
21,453 grants matching “tuberculosis”
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine
$472,273Shabaana A. Khader · University Of Chicago · R61 · FY2024 · AI
Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia
$472,160Omar Khalik Siddiqi · Beth Israel Deaconess Medical Center · R01 · FY2022 · NS
MRI: Acquisition of Spinning Disk Confocal for Multi-Disciplinary Research and Undergraduate Teaching and Training
$472,138Lindsay Lewellyn · Butler University · · FY2021 · BIO
Structural Biology of TB Drug Targets
$472,079David Eisenberg · Texas A&M Agrilife Research · P01 · FY2009 · AI
Chemical Mycobateriology
$472,018Carolyn R Bertozzi · Stanford University · R37 · FY2023 · AI
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
$472,012David H Canaday · Case Western Reserve University · R01 · FY2011 · AI
Development of an Oral Carbapenem Drug for Treatment of Drug Resistant TB
$471,845Gyanu Lamichhane · Johns Hopkins University · R33 · FY2018 · AI
Equipment for Correlative LM/EM by High Pressure Freezing and Tomography
$471,762Kent L. McDonald · University Of California Berkeley · S10 · FY2007 · RR
Project 2: Innate immune responses triggered by M. tuberculosis phagosomal perforation
$471,645Jeffery S Cox · University Of California Berkeley · P01 · FY2025 · AI
Family-Based HIV VCT in Patients at Risk for TB
$471,536Edwin Duncan Charlebois · University Of California, San Francisco · R01 · FY2009 · MH
A genetic dissection of Mendelian susceptibility to mycobacterial diseases (MSMD)
$471,488Jean-Laurent Casanova · Rockefeller University · R01 · FY2013 · AI
Functional Genomics Study and Database for Tuberculosis
$470,884Pacific Tuberculosis &Cancer Res Org · R01 · FY2005 · HL
M. tuberculosis evasion of immune effector mechanisms
$470,842New York University School Of Medicine · R01 · FY2004 · AI
Validation and Application of a Model for Human-like TB Latency in Rabbits
$470,784David Alland · Rbhs-New Jersey Medical School · U19 · FY2019 · AI
Phenotype MicroArray Analysis of Fastidious Pathogens
$470,751Barry Ronald Bochner · Biolog, Inc. · R42 · FY2007 · GM
The role of Ser/Thr/Tyr phosphosignaling in the M. tuberculosis latency switch
$470,750Christoph Grundner · Seattle Children'S Hospital · R01 · FY2020 · AI
The role of Ser/Thr/Tyr phosphosignaling in the M. tuberculosis latency switch
$470,750Christoph Grundner · Seattle Children'S Hospital · R01 · FY2019 · AI
Human T Cell Antigens of Mycobacterium tuberculosis
$470,628Steven G. Reed · Access To Advanced Health Institute · R01 · FY2008 · AI
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeutic nanoparticles for TB
$470,531Jessica L Reynolds · State University Of New York At Buffalo · R01 · FY2020 · AI
TB-TST (TB treatment support tools): Refinement and evaluation of an interactive mobile app and direct adherence monitoring on TB treatment outcomes
$470,452Fernando Adriãn Rubinstein · Instituto De Efectividad Clinica Y Sanit · R01 · FY2021 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$470,441Neel Rajnikant Gandhi · Emory University · P30 · FY2025 · AI
LATENCY AND REACTIVATION TUBERCULOSIS
$470,430Yukari C Manabe · Johns Hopkins University · R01 · FY2006 · HL
Role of ribosome modulating proteins in conferring Mycobacterium abscessus antibiotic resistance
$470,217Pallavi Ghosh · Wadsworth Center · R01 · FY2024 · AI
Structure, Function and Applications of Inteins
$470,104Tom W Muir · Princeton University · R01 · FY2011 · GM
CD4 T Cell Responses to M. Tuberculosis Infection
$470,003Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2010 · AI